CFA Commentary on Sunshine Biopharma, Inc. (OTCBB: SBFM)
Sunshine Biopharma, Inc. -- Targeting the Challenge of Multidrug Resistance in Breast and Lung Cancer by Developing Adva-27a
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 07/30/12 -- InvestorIdeas.com (), an investor research portal specializing in sector research including biotech and pharma stocks, issues CFA commentary by Patrick J. Murphy of Murphy Analytics LLC, on Sunshine Biopharma Inc. (OTCBB: SBFM) and its lead anti-cancer compound, Adva-27a.
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer.
InvestorIdeas.com is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas:
Follow InvestorIdeas.com on Twitter
Follow InvestorIdeas.com on Facebook
Sign up for the free investor news and biotech stock alerts
The InvestorIdeas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated InvestorIdeas.com for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26th.
Patrick Murphy was compensated five hundred dollars for the CFA commentary article.
BC Residents and Investor Disclaimer : Effective September 15 2008 -- all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
InvestorIdeas.com
800-665-0411
Source -
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.07.2012 - 15:57 Uhr
Sprache: Deutsch
News-ID 169840
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 220 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CFA Commentary on Sunshine Biopharma, Inc. (OTCBB: SBFM)"
steht unter der journalistisch-redaktionellen Verantwortung von
InvestorIdeas.com; Sunshine Biopharma Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
